OR WAIT 15 SECS
© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
© 2020 MJH Life Sciences™ and Drug Topics. All rights reserved.
Novartis is set to pay as much as $39 biliion to buy a controlling stake in Alcon, a Houston company that dominates the eye care market.